Related Experiment Videos

[Influence of anticoagulants on the appearance of chronic subdural hematoma]

Mariusz Krupa1, Marek Moskała, Tomasz Składzień

  • 1Z Kliniki Neurotraumatologii CM UJ w Krakowie. krupa@cm-uj.krakow.pl

Przeglad Lekarski
|January 2, 2010
PubMed

Insights

Anticoagulant medications, like aspirin, are frequently linked to chronic subdural hematoma (CSDH). Insufficient control over their use, especially in cardiovascular patients, heightens bleeding risks and CSDH incidence.

Area of Science:

  • Neuroscience
  • Clinical Medicine
  • Pharmacology

Context:

  • The Department of Neurotraumatology in Cracow observed a rise in chronic subdural hematoma (CSDH) cases.
  • A frequent association was noted between CSDH occurrence and anticoagulant medication use.
  • Growing life expectancy in Poland leads to increased use of medications like acetylsalicylic acid.

Purpose:

  • To highlight the issue of inadequate anticoagulant consumption control.
  • To emphasize the increased risk of bleeding and CSDH development in patients on anticoagulants, particularly those with cardiovascular diseases.
  • To draw attention to the potential epidemiological impact of anticoagulant use on CSDH incidence.

Summary:

  • A study analyzed 51 patients with CSDH treated between 2004-2005.
  • A significant majority (72.5%) of patients reported taking acetylsalicylic acid prior to admission.
  • Other anticoagulants like low-molecular weight heparin (17.6%) and coumarin derivatives (1.9%) were also used.

Impact:

  • Anticoagulant therapy may contribute to a higher incidence of chronic subdural hematoma.
  • This finding is particularly relevant given the aging population and widespread use of anticoagulants.
  • Future epidemiological surveillance for CSDH should consider anticoagulant use patterns.

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...